Trevena, Inc. (TRVN) Appoints Robert Prachar As Senior Vice President, Commercial And Corporate Strategy
4/1/2014 7:11:49 AM
Trevena, Inc. (NASDAQ:TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the appointment of Robert Prachar to the newly created position of Senior Vice President, Commercial and Corporate Strategy, effective immediately. Mr. Prachar, who has served as a full-time consultant for the Company since August 2013, brings over 20 years of commercial leadership experience in the life sciences industry.
Help employers find you! Check out all the jobs and post your resume.
comments powered by